Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | CTSG | P08311 | 5/20 | 0.37 |
| ▸ | CMA1 | P23946 | 4/20 | 0.37 |
| ▸ | LTA4H | P09960 | 2/20 | 0.35 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.35 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.35 |
| ▸ | EGFR | P00533 | 1/20 | 0.33 |
| ▸ | CYP4Z1 | Q86W10 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2291756 | 1.00 | GAA (0.37) | GAACTSGCMA1LTA4HCYP4F2 | |
| SCHEMBL2291750 | 1.00 | GAA (0.37) | GAACTSGCMA1LTA4HCYP4F2 | |
| SCHEMBL4603498 | 0.92 | CYP4F2 (0.39) | GAACTSGCMA1LTA4HCYP4F2 | |
| SCHEMBL2293437 | 0.92 | CYP4F2 (0.39) | GAACTSGCMA1LTA4HCYP4F2 | |
| SCHEMBL2293441 | 0.92 | CYP4F2 (0.39) | GAACTSGCMA1LTA4HCYP4F2 | |
| SCHEMBL8241139 | 0.89 | CTSG (0.33) | GAACTSGCMA1 | |
| SCHEMBL3600555 | 0.87 | SMN1; SMN2 (0.39) | CYP4F2CYP4A11 | |
| SCHEMBL2294774 | 0.84 | CYP4Z1 (0.39) | CTSGCMA1LTA4HCYP4F2CYP4A11 | |
| SCHEMBL7007227 | 0.84 | LTA4H (0.38) | CTSGCMA1LTA4HCYP4Z1 | |
| SCHEMBL2293418 | 0.82 | CTSG (0.37) | CTSGCMA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1940809-A1 | TETRAZOL DERIVATIVES AND THEIR USE FOR THE TREATMENT OF CARDIOVASCULAR DISEASES | Bayer HealthCare AG (DE) | 2008-07-09 | — | — | EP | disclosed |
| EP-1940811-A1 | HETEROCYCLIC COMPOUNDS WITH CARBOXYL ISOSTERE GROUPS AND THEIR USE FOR THE TREATMENT OF CARDIOVASCULAR DISEASES | Bayer HealthCare AG (DE) | 2008-07-09 | — | — | EP | disclosed |
| WO-2007045370-A1 | TETRAZOL DERIVATIVES AND THEIR USE FOR THE TREATMENT OF CARDIOVASCULAR DISEASES | BAYER HEALTHCARE AG (DE) | 2007-04-26 | — | — | WO | disclosed |
| WO-2007045366-A1 | HETEROCYCLIC COMPOUNDS WITH CARBOXYL ISOSTERE GROUPS AND THEIR USE FOR THE TREATMENT OF CARDIOVASCULAR DISEASES | BAYER HEALTHCARE AG (DE) | 2007-04-26 | — | — | WO | disclosed |